TP53 MB was higher in patients with ovarian cancer with borderline significance ( P = 0.055).
also in 7,017 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.